Final Report of E1484: CHOP vs CHOP + Radiotherapy (RT) for Limited Stage Diffuse Aggressive Lymphoma

Reviewer: Mary Kara Bucci, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 10 de diciembre del 2001

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASTRO: Cisplatin Plus RT, HDRB Beneficial for Cervical Cancer

Oct 4, 2013

Disease-free survival up with chemoradiotherapy, high-dose-rate brachytherapy in stage IIIB disease

High-Dose Hypofractionated RT Palliative in Head, Neck Cancer

Nov 27, 2015

Meaningful palliative effect for 63 percent of patients, lasting for median of 4.6 months

Survival Advantage of ADT+RT in Prostate CA Extends to Older Men

Jan 6, 2015

Reduced cause-specific, all-cause mortality for older men with locally-advanced, screen-detected disease